.Merck defeats earnings assumptions, brings up purchases overview on strong need for best medications like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Forecasts as Keytruda Sales Increase BloombergMerck Supply: Pharma Giant Posts Strong Outcomes, But Outlook Tumbles Short Client's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats profit as well as purchases expectations amid Keytruda asset, yet offers combined full-year expectation MarketWatch.